CYP1A2 and cancer: Similarly, differences in CYP1A2 activity might alter the balance of CAF anti-oxidant versus pro-oxidant action in tissues: a slow metabolizer might experience sustained activation of pathways like SIRT3/SOD2 (extended anti-oxidant effect) and prolonged inhibition of DNA repair checkpoints (extended pro-oxidant stress on cancer cells).